MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
269.84
-4.92
-1.79%
Opening 11:00 05/13 EDT
OPEN
273.63
PREV CLOSE
274.76
HIGH
273.92
LOW
268.53
VOLUME
617.38K
TURNOVER
--
52 WEEK HIGH
338.98
52 WEEK LOW
251.27
MARKET CAP
145.09B
P/E (TTM)
24.63
1D
5D
1M
3M
1Y
5Y
1D
Medicare to publish drugs selected for third round of price negotiations by Feb. 1
Seeking Alpha · 2h ago
Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared
NASDAQ · 3h ago
Amgen Stock May Get Fatter Premiums As It Slims Down Obesity Drug Competition with MariTide
TipRanks · 4h ago
Noteworthy Monday Option Activity: MO, AMGN, T
NASDAQ · 21h ago
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
Seeking Alpha · 22h ago
Fund Update: Capital World Investors Just Disclosed New Holdings
NASDAQ · 22h ago
BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order
Reuters · 1d ago
Innovation, pharma profits won't suffer under Trump prescription drug EO - White House
Seeking Alpha · 1d ago
More
About AMGN
More
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.
Recently
Symbol
Price
%Change

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.